Global Whole Genome Amplification Market Overview:
WGA stands for whole genome amplification, which is a technique for amplifying the complete DNA from a tiny sample of genomic DNA. WGA is gaining popularity since it aids in increasing the number of restricted DNA samples. This method is used to examine any gene in any organism using a restricted sample that has been kept. This application is widely used in a wide range of applications, including genetic disease research and forensics, among others. The polymerase chain reaction is used to enzymatically copy DNA from a genome sample in the whole genome amplification method.
- Increasing adoption of whole genome amplification (WGA) for the examination of sequence
- Rising incidence of cancer, cardiovascular ailments, and heart disease
- Lack of trust in the process
- Development of advanced devices and kits
- Introduction of novel techniques
The companies are determining the industry in new geographical areas by adopting various strategic growth areas such as mergers & acquisitions, expansions, investments, new product launches, and others. The market key players are exploring new areas through growths and achievements across the globe to benefit from competitive advantage through combined synergies.
Some of the key players profiled in the report are Merck KGaA (Germany), QIAGEN (Germany), GENERAL ELECTRIC COMPANY (United States), LGC Limited (United Kingdom), Illumina, Inc. (United States), Thermo Fisher Scientific, Inc. (United States), Eurofins Scientific (Luxembourg), Agilent Technologies, Inc. (United States), Oxford Nanopore Technologies (United Kingdom), F. Hoffmann-La Roche Ltd (Switzerland) and Bio-Rad Laboratories, Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Whole Genome Amplification market by 2026. Considering Market by End User, the sub-segment i.e. Pharma and Biotech Companies will boost the Whole Genome Amplification market.
In October 2020, BioSkryb launched its new ResolveDNATM kits incorporated with primary template-directed amplification (PTA) technology, to accurately and uniformly amplify the genomes of single cells.
What Can be Explored with the Whole Genome Amplification Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Whole Genome Amplification Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Whole Genome Amplification
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Whole Genome Amplification market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Whole Genome Amplification market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Whole Genome Amplification Provider, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Frequently Asked Questions (FAQ):1. What is the growth rate predicted for the Global Whole Genome Amplification Market?
The Whole Genome Amplification market is expected to see a CAGR of % during projected year 2020 to 2026.
2. Who are the top performing companies in Whole Genome Amplification Market?
Top performing companies in the Global Whole Genome Amplification market are Merck KGaA (Germany), QIAGEN (Germany), GENERAL ELECTRIC COMPANY (United States), LGC Limited (United Kingdom), Illumina, Inc. (United States), Thermo Fisher Scientific, Inc. (United States), Eurofins Scientific (Luxembourg), Agilent Technologies, Inc. (United States), Oxford Nanopore Technologies (United Kingdom), F. Hoffmann-La Roche Ltd (Switzerland) and Bio-Rad Laboratories, Inc. (United States), to name a few.
3. What trending factors would impact Whole Genome Amplification Market growth most?
"Increasing innovation to increase the reliability of the wide range of whole genome amplification kits" is seen as one of major influencing trends for Whole Genome Amplification Market during projected period 2020-2026.